IMMUPHARMA (LSE:IMM)

56.00
Today's low: 55.26
Sell IMM
57.00
Today's high: 57.50
Buy IMM
Last trade:
56.25
Change:
 -1.25 (-2.17%)
Volume:
144,926
Delayed price:
17-04-2014 16:35:18
SETSqx
GBX

IMMUPHARMA News (IMM,IMM.L,LSE:IMM)

Latest News

ImmuPharma Sponsors the 2014 European Lupus Confer

RNS Number : 5939E Immupharma PLC 11 April 2014 FOR IMMEDIATE RELEASE RNS REACH 11 APRIL 2014 ImmuPharma Sponsors the 2014 European Lupus Conference Presentation Date: 24 April 2014 ImmuPharma PLC (LSE: IMM), (ImmuPharma or the Company), the specialist drug discovery and development company, is pleased to confirm that it is sponsoring the forthcoming European Lupus Conference which takes place in Athens, Greece from April 23 - 26, ...

Additional Listing

RNS Number : 3736Q Immupharma PLC 14 October 2013 FOR IMMEDIATE RELEASE 14 OCTOBER 2013 ImmuPharma plc ADDITIONAL LISTING AND TOTAL VOTING RIGHTS ImmuPharma plc (LSE:IMM) (Immupharma or the Company), the specialist discovery and development pharmaceutical company announces that following the exercise of warrants held by the Darwin Strategic Limited (Darwin), application has been made to the London Stock Exchange for the admission of ...

ImmuPharma trims operating loss

ImmuPharma posts operating losses of 1.8m for the six months to the of June - down from 1.97m last time. Pre-tax losses rose slightly to 1.8m from 1.77m and the loss for the period was unchanged at 1.8m. Chief executive Dimitri Dimitriou said: We are delighted and excited with the progress we made on the advancement of development of our lead compound LupuzorTM towards Phase III trials, specifically the updated SPA from the FDA, the ...

All News

DateHeadlineSource
11-04-2014ImmuPharma Sponsors the 2014 European Lupus ConferRNS
14-10-2013Additional ListingRNS
27-09-2013ImmuPharma trims operating lossStockMarketWire
27-09-2013Half Yearly ReportRNS
13-08-2013ImmuPharma gives update on cancer programmeStockMarketWire
13-08-2013UPDATE CANCER PROGRAMME IPP-204106RNS
31-07-2013FDA GRANTS IMMUPHARMA AMENDED SPARNS
08-07-2013ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-2013ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-2013IMMUPHARMA APPOINTS WORLDWIDE KEY OPINION LEADERSRNS
05-06-2013Holding(s) in CompanyRNS
23-05-2013Result of AGMRNS
21-05-2013ImmuPharma agrees £50 financingStockMarketWire
21-05-2013?50M Financing Facility - Darwin StrategicRNS
22-04-2013Posting of Annual Report and AGM NoticeRNS
09-04-2013ImmuPharma losses riseStockMarketWire
09-04-2013Preliminary ResultsRNS
28-02-2013ImmuPharma starts trading on Stuttgart ExchangeStockMarketWire
28-02-2013ImmuPharma Commences Trading on Stuttgart ExchangeRNS
28-01-2013Director Deals - ImmuPharma PLC (IMM)StockMarketWire
28-01-2013Director/PDMR Shareholding - ReplacementRNS
28-01-2013Director Deals - ImmuPharma PLC (IMM)StockMarketWire
28-01-2013Director/PDMR ShareholdingRNS
28-01-2013CNRS confirms Lupuzor's effectivenessStockMarketWire
28-01-2013CNRS Confirms Lupuzor's (TM) EffectivenessRNS
15-11-2012Lupuzor PresentationRNS
05-11-2012Lupuzor PresentationRNS
03-10-2012Notification of Major Interest in SharesRNS
26-09-2012Markets: Global growth fears hit FTSE 100 on WednesdayInteractive Investor
26-09-2012First Cancer Patients in New Trial Begin DosingRNS
26-09-2012Interim ResultsRNS
26-09-2012What's in store today...Interactive Investor
21-09-2012The week ahead...Interactive Investor
20-09-2012Notification of Interim ResultsRNS
07-09-2012Rodman and Renshaw ConferenceRNS
17-08-2012Notification of Major Interest in SharesRNS
11-07-2012Voted Best Medical Research & Development CompanyRNS
09-07-2012New Corporate WebsiteRNS
03-07-2012Appointment of Joint BrokerRNS
23-05-2012Annual General Meeting: 2012RNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory